The creation of sympathetic-cardiac assembloids offers a new in vitro model for studying autonomic neuromodulation and cardiometabolic diseases.
Liu et al.1 generate human sympathetic ganglion organoids and assemble them with heart-forming organoids to build functionally connected sympathetic-cardiac organoids in vitro. Their platform captures autonomic development, neuromodulation of heart function, and metabolic injury, opening new opportunities to study human autonomic disorders and cardiometabolic disease.2.
Nam et al. (Thu,) studied this question.